Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: Implications for neuropsychiatric diseases

Neuroscience

Volumn 207, Issue , 2012, Pages 274-282

  Adams, C E ^a,b   Yonchek, J C ^a,b   Schulz, K M ^b   Graw, S L ^b   Stitzel, J ^c   Teschke, P U ^b   Stevens, K E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Chrna7; GABA; GABAA receptors; GAT 1; Hippocampus; Nicotinic receptors

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BUNGAROTOXIN RECEPTOR; GLUTAMATE DECARBOXYLASE 65; GLUTAMIC ACID; MOLECULAR MARKER; VESICULAR INHIBITORY AMINO ACID TRANSPORTER;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL TISSUE; ARTICLE; AUTISM; CELL ACTIVITY; CHRNA7 GENE; CHROMOSOME 15Q; CONTROLLED STUDY; ENZYME REGULATION; EPILEPSY; EXCITATORY JUNCTION POTENTIAL; FEMALE; GABAERGIC SYSTEM; GENE; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; HETEROZYGOTE; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MENTAL DISEASE; MOUSE; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PYRAMIDAL NERVE CELL; RECEPTOR DENSITY; SCHIZOPHRENIA; SENSORY STIMULATION; WILD TYPE;

ANIMALS; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL INHIBITION; RECEPTORS, NICOTINIC; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 84858440288     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.01.033     Document Type: Article

References (57)

1. Adams C.E., Broide R.S., Chen Y., Winzer-Serhan U.H., Henderson T.A., Leslie F.M., Freedman R. Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res Dev Brain Res 2002, 139:175-187.
2. Adams C.E., Stevens K.E. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Front Biosci 2007, 12:4755-4772.
3. Adams C.E., Yonchek J.C., Zheng L., Collins A.C., Stevens K.E. Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. Brain Res 2008, 1194:138-145.
4. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009, 89:73-120.
5. Ancín I., Barabash A., Vázquez-Álvarez B., Santos J.L., Sánchez-Morla E., Martínez J.L., Aparicio A., Peláez J.C., Díaz J.A. Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with schizophrenia. Psychiatr Genet 2010, 20:289-297.
6. Barnes E.M. Use-dependent regulation of GABAA receptors. Int Rev Neurobiol 1996, 39:53-76.
7. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
8. A receptor binding in the hippocampal formation of schizophrenic brain. Synapse 1996, 22:338-349.
9. A receptor subunit expression in schizophrenia. Cereb Cortex 2011, 21:999-1011.
10. Bernstein E.M., Quick M.W. Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA. J Biol Chem 1999, 274:889-895.
11. Bertrand D. Neurocircuitry of the nicotinic cholinergic system. Dialogues Clin Neurosci 2010, 12:463-470.
12. Bitner R.S., Bunnelle W.H., Anderson D.J., Briggs C.A., Buccafusco J., Curzon P., Decker M.W., Frost J.M., Gronlien J.H., Gubbins E., Li J., Malysz J., Markosyan S., Marsh K., Meyer M.D., Nikkel A.L., Radek R.J., Robb H.M., Timmermann D., Sullivan J.P., Gopalakrishnan M. Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J Neurosci 2007, 27:10578-10587.
13. Blatt G.J., Fatemi S.H. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat Rec (Hoboken) 2011, 294:1646-1652.
14. Brunig I., Penschuck S., Berninger B., Benson J., Fritschy J.M. BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABA(A) receptor surface expression. Eur J Neurosci 2001, 13:1320-1328.
15. Cubells J.F., Deoreo E.H., Harvey P.D., Garlow S.J., Garber K., Adam M.P., Martin C.L. Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. Am J Med Genet A 2011, 155A:805-810.
16. Eid T., Williamson A., Lee T.S., Petroff O.A., de Lanerolle N.C. Glutamate and astrocytes-key players in human mesial temporal lobe epilepsy?. Epilepsia 2008, 49(Suppl 2):42-52.
17. Fabian-Fine R., Skehel P., Errington M.L., Davies H.A., Sher E., Stewart M.G., Fine A. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 2001, 21:7993-8003.
18. Freedman R., Wetmore C., Strömberg I., Leonard S., Olson L. Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci 1993, 13:1965-1975.
19. Gabor R., Nagle R., Johnson D.A., Gibbs R.B. Estrogen enhances potassium-stimulated acetylcholine release in the rat hippocampus. Brain Res 2003, 962:244-247.
20. Glausier J.R., Lewis D.A. Selective pyramidal cell reduction of GABA(A) receptor alpha1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology 2011, 36:2103-2110.
21. Gonzalez-Flores O., Sanchez N., Garcia-Juarez M., Lima-Hernandez F.J., Gonzalez-Mariscal G., Beyer C. Estradiol and testosterone modulate the anesthetic action of the GABA-A agonist THIP, but not of the neurosteroid 3alpha,5beta-pregnanolone in the rat. Psychopharmacology (Berl) 2004, 172:283-290.
22. Gubbins E.J., Gopalakrishnan M., Li J. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells. Brain Res 2010, 1328:1-11.
23. Heckers S., Konradi C. Hippocampal pathology in schizophrenia. Curr Top. Behav Neurosci 2010, 4:529-553.
24. Helbig I., Mefford H.C., Sharp A.J., Guipponi M., Fichera M., Franke A., Muhle H., de Kovel C., Baker C., von Spiczak S., Kron K.L., Steinich I., Kleefuss-Lie A.A., Leu C., Gaus V., Schmitz B., Klein K.M., Reif P.S., Rosenow F., Weber Y., Lerche H., Zimprich F., Urak L., Fuchs K., Feucht M., Genton P., Thomas P., Visscher F., de Haan G.J., Møller R.S., Hjalgrim H., Luciano D., Wittig M., Nothnagel M., Elger C.E., Nürnberg P., Romano C., Malafosse A., Koeleman B.P.C., Lindhout D., Stephani U., Schreiber S., Eichler E.E., Sander T. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009, 41:160-162.
25. Hu M., Liu Q.S., Chang K.T., Berg D.K. Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways. Mol Cell Neurosci 2002, 21:616-625.
26. Lee T.S., Bjørnsen L.P., Paz C., Kim J.H., Spencer S.S., Spencer D.D., Eid T., de Lanerolle N.C. GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus. Acta Neuropathol 2006, 111:351-363.
27. Liu Z., Neff R.A., Berg D.K. Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science 2006, 314:1610-1613.
28. Lund I.V., Hu Y., Raol Y.H., Benham R.S., Faris R., Russek S.J., Brooks-Kayal A.R. BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway. Sci Signal 2008, 1:ra9.
29. Luscher B., Fuchs T., Kilpatrick C.L. GABAA receptor trafficking-mediated plasticity of inhibitory synapses. Neuron 2011, 70:385-409.
30. Maggi L., Le Magueresse C., Changeux J.P., Cherubini E. Nicotine activates immature "silent" connections in the developing hippocampus. Proc Natl Acad Sci U S A 2003, 100:2059-2064.
31. Maggi L., Sher E., Cherubini E. Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus. J Physiol 2001, 536:89-100.
32. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992, 38:379-395.
33. Marsden K.C., Beattie J.B., Friedenthal J., Carroll R.C. NMDA receptor activation potentiates inhibitory transmission through GABA receptor-associated protein-dependent exocytosis of GABA(A) receptors. J Neurosci 2007, 27:14326-14337.
34. Martin D.L., Tobin A.J. Mechanisms controlling GABA synthesis and degradation in the brain. GABA in the nervous system: the view at fifty years 2000, 25-41. Lippincott Williams and Wilkins, Philadelphia. D.L. Martin, R.W. Olsen (Eds.).
35. Masurel-Paulet A., Andrieux J., Callier P., Cuisset J.M., Le Caignec C., Holder M., Thauvin-Robinet C., Doray B., Flori E., Alex-Cordier M.P., Beri M., Boute O., Delobel B., Dieux A., Vallee L., Jaillard S., Odent S., Isidor B., Beneteau C., Vigneron J., Bilan F., Gilbert-Dussardier B., Dubourg C., Labalme A., Bidon C., Gautier A., Pernes P., Pinoit J.M., Huet F., Mugneret F., Aral B., Jonveaux P., Sanlaville D., Faivre L. Delineation of 15q13.3 microdeletions. Clin Genet 2010, 78:149-161.
36. Mou L., Heldt S.A., Ressler K.J. Rapid brain-derived neurotrophic factor-dependent sequestration of amygdala and hippocampal GABA(A) receptors via different tyrosine receptor kinase B-mediated phosphorylation pathways. Neuroscience 2011, 176:72-85.
37. Murphy D.D., Cole N.B., Segal M. Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons. Proc Natl Acad Sci U S A 1998, 95:11412-11417.
38. Olsen R.W., McCabe R.T., Wamsley J.K. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system. J Chem Neuroanat 1990, 3:59-76.
39. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin bindng sites and hippocampal fast nicotinic currents. J Neurosci 1997, 17:9165-9171.
40. Page L.A., Daly E., Schmitz N., Simmons A., Toal F., Deeley Q., Ambery F., McAlonan G.M., Murphy K.C., Murphy D.G. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006, 163:2189-2192.
41. A receptors. J Pharmacol Exp Ther 2010, 334:1031-1041.
42. Scharfman H.E., Mercurio T.C., Goodman J.H., Wilson M.A., MacLusky N.J. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor. J Neurosci 2003, 23:11641-11652.
43. Schleimer S.B., Hinton T., Dixon G., Johnston G.A. GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia. Neuropsychobiology 2004, 50:226-230.
44. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol 2008, 29:219-237.
45. Sperk G., Drexel M., Pirker S. Neuronal plasticity in animal models and the epileptic human hippocampus. Epilepsia 2009, 50(Suppl 12):29-31.
46. Stephens S.H., Franks A., Berger R., Palionyte M., Fingerlin T.E., Wagner B., Logel J., Olincy A., Ross R.G., Freedman R., Leonard S. Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatr Genet 2012, 22:1-14.
47. Taske N.L., Williamson M.P., Makoff A., Bate L., Curtis D., Kerr M., Kjeldsen M.J., Pang K.A., Sundqvist A., Friis M.L., Chadwick D., Richens A., Covanis A., Santos M., Arzimanoglou A., Panayiotopoulos C.P., Whitehouse W.P., Rees M., Gardiner R.M. Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14. Epilepsy Res 2002, 49:157-172.
48. Tregellas J.R., Davalos D.B., Rojas D.C., Waldo M.C., Gibson L., Wylie K., Du Y.P., Freedman R. Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res 2007, 92:262-272.
49. van Bon B.W., Mefford H.C., Menten B., Koolen D.A., Sharp A.J., Nillesen W.M., Innis J.W., de Ravel T.J., Mercer C.L., Fichera M., Stewart H., Connell L.E., Ounap K., Lachlan K., Castle B., Van der Aa N., van Ravenswaaij C., Nobrega M.A., Serra-Juhé C., Simonic I., de Leeuw N., Pfundt R., Bongers E.M., Baker C., Finnemore P., Huang S., Maloney V.K., Crolla J.A., van Kalmthout M., Elia M., Vandeweyer G., Fryns J.P., Janssens S., Foulds N., Reitano S., Smith K., Parkel S., Loeys B., Woods C.G., Oostra A., Speleman F., Pereira A.C., Kurg A., Willatt L., Knight S.J., Vermeesch J.R., Romano C., Barber J.C., Mortier G., Perez-Jurado L.A., Kooy F., Brunner H.G., Eichler E.E., Kleefstra T., de Vries B.B. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009, 46:511-523.
50. Volk D.W., Lewis D.A. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 2002, 77:501-505.
51. Wanaverbecq N., Semyanov A., Pavlov I., Walker M.C., Kullmann D.M. Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic alpha7 nicotinic receptors. J Neurosci 2007, 27:5683-5693.
52. Wardle R.A., Poo M.M. Brain-derived neurotrophic factor modulation of GABAergic synapses by postsynaptic regulation of chloride transport. J Neurosci 2003, 23:8722-8732.
53. Wei J., Davis K.M., Wu H., Wu J.Y. Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications. Biochemistry 2004, 43:6182-6189.
54. Wei J., Wu J.Y. Post-translational regulation of l-glutamic acid decarboxylase in the brain. Neurochem Res 2008, 33:1459-1465.
55. Yasui D.H., Scoles H.A., Horike S., Meguro-Horike M., Dunaway K.W., Schroeder D.I., Lasalle J.M. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum Mol Genet 2011, 20:4311-4323.
56. Zahniser N.R., Doolen S. Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 2001, 92:21-55.
57. Zhang J., Berg D.K. Reversible inhibition of GABAA receptors by alpha 7-containing nicotinic receptors on the vertebrate postsynaptic neurons. J Physiol 2007, 579:753-763.